1. Kandimalla R+, Wang W+, Yu F, Zhou N, Gao F, Spillman M, Moukova L, Slaby O, Salhia B, Zhou S*, Wang X*, Goel A*. OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study, Clinical Cancer Research 2021. doi: 10.1158/1078-0432.CCR-21-0267. Epub 2021 May 25. PMID: 34035068; PMCID: PMC10327469.
|
2. Huang H+, Hu J+, Maryam A, Huang Q, Zhang Y, Ramakrishnan S, Li J, Ma H, Ma VWS, Cheuk W, So GYK, Wang W, Cho WCS, Zhang L, Chan KM, Wang X*, Chin YR*. Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling, Nature Communications 2021, 21:1-16.
|